Bigelow Investment Advisors LLC Has $2.16 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Bigelow Investment Advisors LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,269 shares of the healthcare conglomerate’s stock after selling 579 shares during the period. UnitedHealth Group makes up approximately 1.0% of Bigelow Investment Advisors LLC’s investment portfolio, making the stock its 23rd biggest position. Bigelow Investment Advisors LLC’s holdings in UnitedHealth Group were worth $2,160,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in UNH. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $30,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group during the third quarter valued at about $37,000. DecisionPoint Financial LLC raised its holdings in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares during the period. Highline Wealth Partners LLC acquired a new position in shares of UnitedHealth Group during the third quarter valued at about $55,000. Finally, Legacy Investment Solutions LLC acquired a new position in shares of UnitedHealth Group during the third quarter valued at about $57,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 4.2 %

UNH opened at $501.52 on Wednesday. The company has a 50 day moving average of $521.08 and a 200 day moving average of $562.03. The company has a market cap of $461.54 billion, a PE ratio of 32.36, a price-to-earnings-growth ratio of 1.43 and a beta of 0.61. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the company posted $5.83 EPS. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on UNH shares. Piper Sandler lowered their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and an average target price of $629.32.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.